Diabetic macular oedema (DMO) is the major cause of visual impairment in people with
diabetes. Optical coherence tomography (OCT) is now the most widely used modality to …

Diabetic macular edema (DME)'s therapeutic approach can frequently be challenging. The
purpose of the review is to propose evidence-based recommendations on the employment …

OBJECTIVE To investigate quantitative and qualitative changes in retinal structure using
optical coherence tomography (OCT) and their associations with systemic or other risk …

Randomised clinical trials (RCTs) are generally considered the gold-standard for providing
scientific evidence for treatments' effectiveness and safety but their findings may not always …

Purpose Evaluate the differences between clinical visual acuity (VA) as recorded in medical
records and electronic Early Treatment Diabetic Retinopathy Study (eETDRS) protocol VA …

Abstract In the United Arab Emirates, retinopathy has been shown to be present in 19% of
the diabetic population, with diabetes identified in up to 40% of individuals aged over 55 …

Purpose This meta-analysis aims to summarize 12-month best-corrected visual acuity
(BCVA) outcomes in response to anti-vascular endothelial growth factor (VEGF) therapy and …

The science of diabetes care has progressed to provide a better understanding of the
oxidative and inflammatory lesions and pathophysiology of the neuro-vascular unit within …

Purpose: To identify clinical and anatomic factor–associated vision loss in eyes with
treatment-naïve diabetic macular edema and good initial visual acuity. Methods …

Background: During the first COVID-19 pandemic outbreak, a new triage concept had to be
implemented for patients with retinal diseases having a scheduled appointment at the …